Sunday, June 5, 2022

Publications of DH Marks



PUBLICATIONS of Donald Harvey Marks

Science 


  1. TenEyck R, Schaerdel AD, Lynett JE, Marks DH, et al: Stroma-free methemoglobin solution as an antidote for cyanide poisoning. A preliminary study.  Clinical Toxicology 21(3):343-358, 1984.

  1. Marks DH, et al: Pelvic hematoma after intercourse while on chronic anticoagulation. Annals of Emergency Medicine 13:554-556, 1984.

  1. Marks DH, Patressi J, Chaudry IH: Effect of pyridoxalated stabilized stroma-free hemoglobin solution on the clearance of intravascular lipid by the reticuloendothelial system. Circulatory Shock 16:165-172, 1985.

  1. Moore GL, Ledford ME, Marks DH: Clinical trials of an optimized additive solution for red cell storage which also preserves 2,3-DPG. Transfusion, Dec 1986.

  1. Marks DH, et al: Pyridoxalated polymerized stroma-free hemoglobin solution for hemorrhagic shock in dogs. Military Med. 152(5):265-271, 1987.

  1. Marks DH, et al: Antibody Response to Transfusion With Pyridoxalated glutaraldehyde-treated Hemoglobin Solution. Mil Med 152(9):473-477, 1987.

  1. Marks DH, Hou KC, Medina F, Bolin RB. Removal of bacteria from blood.. Mil Med. 1987 Mar;152(3):156-60.

  1. Marks DH, et al.: Optimization of synthesis of pyridoxalated  polymerized stroma-free hemoglobin solution. Mil Med 153:44-49, 1988.

  1. Marks DH et al: Efficiency of Antibacterial Membrane and effect on Blood Components. Mil Med 153(7):337-340, 1988.

  1. Davidson IJA, Drukkerr S, Hedlund B, Marks DH et al:  Deleterious Effects of Stroma-free Hemoglobin Used As Resuscitative Fluid For Rats With Ischemic Intestinal Shock. Crit Care Med 16(6):606-609, 1988.

  1.  Marks DH, Medina F, Lee S, Blackmon A, Schuschereba ST.et al: Marks, D H (1988). "Removal of bacteria from blood by charcoal hemoperfusion". Biomaterials, artificial cells, and artificial organs (0890-5533), 16 (1-3), p. 135.

  1. Moore GL, Marks DH, et al: Ascorbate-2-phosphate in Red Cell Preservation: Clinical Trials and Active Components. Transfusion 26(3):221-225, 1988.

  1. Marks DH, et al.: Effect of Polymyxin B on in vivo hepatoxicity of hemoglobin. Mil Med 154(4):180-184, 1989.

  1. Keller, D, Koster, FT, Marks, DH et al. Safety and Immunogenicity of a Recombinant Outer Surface Protein A Lyme Vaccine. JAMA, June 8, 1994, p 1764-1768.

  1. Sigal LH,  Zahradnik JM,  Lavin P,  Patella SJ,  Bryant G,  Haselby R,  Hilton E,  Kunkel M,  Adler-Klein D,  Doherty T,  Evans J,  Molloy PJ,    Seidner AL,  Sabetta JR,  Simon HJ,  Klempner MS,  Mays J,  Marks D,   Malawista SE  A vaccine consisting of recombinant Borrelia burgdorferi outer surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A. Lyme Disease Vaccine Study Consortium. N Engl J Med (1998 Jul 23) 339(4):216-22.

  1. Kanesa-thasan N, Smucny JJ, Hoke CH, Marks DH, Konishi E, Kurane I, Tang DB      Vaughn DW, Mason PW, Shope RE.   Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans. Vaccine (2000 Oct 15) 19(4-5):483-91.

  1. VanKampen KR, Shi Z, Gao P, Zhang J, Foster KW, Chen DT, Marks D, Elmets CA, and Tang DC. 2004. Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. Vaccine. 2005 Jan 11;23(8):1029-36.

  1. Marks DH, Adineh M, Gupta S: Determination of Truth from Deception Using Functional MRI and Cognitive Engrams. The Internet Journal of Radiology [peer-reviewed serial on the Internet]. 2006. Volume 5, Number 1. 

  1. Marks DH, Adineh M, Wang B, Gupta S, Udupa JK. Multidimensional Representation of Concepts as Cognitive Engrams in the Human Brain. The Internet Journal of Neurology [peer-reviewed serial on the Internet]. 2007. Volume 6, Number 1.  

  1. Marks DH, Adineh M, Wang B, Gupta S.  Use of fMRI to Predict Psychiatric Adverse Effects of Interferon Treatment for Hepatitis C. Neuropsychiatric Disease and Treatment. 2007:3(5) 655-667.

  1. Marks DH. Cardiomyopathy Due to Ingestion of Adderall. American Journal of Therapeutics. 15(3):287-289, May/June 2008.

  1. Marks DH. Depression Leading to Suicide As An Adverse Effect of Metoclopramide. Internet Journal of Gastroenterology [peer-reviewed serial on the Internet]. 2007. Volume 5(2).  

  1. Marks DH. Dangers of OTC Herbal Supplements: Dilated Cardiomyopathy after Ingestion of TRIAC (triiodothyroacetic acid, Tiratricol). Internet Journal of Endocrinology [peer-reviewed serial on the Internet]. 2007. Volume 3(2).  

  1. Marks DH and Milby J. Interferon and Risk for Drug-Seeking Behavior. Internet Journal of Pain, Symptom Control and Palliative Care [peer-reviewed serial on the Internet]. 2009, 6(2).   

  2. Marks DH, Breggin PR, Braslow D.  Homicidal Ideation Causally Related To Therapeutic Medications. Ethical Human Psychology and Psychiatry, 10 (3), 2008.

Simultaneously published by agreement in The International Journal of Risk and Safety in Medicine, Volume 20 (4),  2008, pp 231-240.

26. Marks DH, Adineh M, Gupta S. MR Imaging of Drug-Induced Suicidal Ideation. Internet J Radiology [peer-reviewed serial on the Internet], 9(1). 2008.  

27. Marks DH. Evaluation of Cognitive Impairment. Internet  J Health. [peer-reviewed serial on the Internet]. 8(1), 2008. 

28. Marks DH, Allison J, Ahmed S, Jeffers LJ, Morgan JR, Morgan PM. The Association of Race/Ethnicity, Sex, and Comorbidity with Hepatitis C Genotype 1 Treatment Response, Internet Journal of Gastroenterology [peer-reviewed serial on the Internet]. 7(2), 2008.  

29. Marks DH. Case Report: Drug Toxicity Leading to Vanishing Bile Duct Syndrome and Cholestatic Jaundice. Internet Journal of Gastroenterology [peer-reviewed serial on the Internet]. 2009, Vol 8(1). 

 30. Marks DH, Valsasina P, Rocca M and Filippi M. Case Report: Documentation of Acute Neck Pain in a Patient Using Functional MR Imaging.  Internet Journal of Pain, Symptom Control and Palliative Care [peer-reviewed serial on the Internet]. 2010, Vol 8(1)

31. Marks DH. Neurologic Complications of Vaccination with Outer Surface Protein A (OspA). The International Journal of Risk and Safety in Medicine, 2011 Jan 1;23(2):89-96.

32. Marks DH. Drug Utilization, Safety and Clinical Use of Actos and Avandia. The International Journal of Risk and Safety in Medicine. Volume 25, Number 1 / 2013, pp 39-51.


Non-Peer Reviewed Articles

  1. Marks DH. Evaluation of Medical Causation, in Drug Injury: Liability, Analysis and Prevention, ,  O’Donnell JT  editor. L&J Publications,  2012-2022.  https://bit.ly/3949Xtr

  1. Marks DH and Middlekoop T. Accutane: Focus on Psychiatric Toxicity and Suicide, in Drug Injury: Liability, Analysis and Prevention, Second Edition, Chapter 20. O’Donnell JT editor. L&J Publications, 2005. https://bit.ly/3xO1ODQ

  2. Marks DH. Minimal Length of Exposure to Vioxx Necessary for Toxicity, MEALEY’S LITIGATION REPORT: Arthritis Drugs Vol. 3, #1 June 2006.

  3. Marks DH. Liver Toxicity At Normal Doses Of Acetaminophen. MEALEY’S LITIGATION REPORT: Arthritis Drugs Vol. 3, #3 August 2006

  1. Marks DH. Interrogation Using Functional MRI and Cognitive Engrams. The Journal of the Institute of Justice and International Studies, vol 8, 2008, pp 31-37.

  1. Marks DH. Drug Induced Liver Disease, in Drug Injury: Liability, Analysis and Prevention, Third Edition. O’Donnell JT editor. L&J Publications, 2012

  2. Drug Induced Liver Disease : Primer for the Primary Care Physician. Disease-A-Month, February 2014. 

  3. Demonstrated or Purported Medical Benefits of Marijuana, http://bit.ly/35wq8ye


Essays


Medical Fiction, available on Amazon and Kindle


Author Image

About Donald H. Marks
Believer in reason, ethics, and social justice, veteran, physician, testifying expert, and author.

By at 11:35 AM
Labels:

No comments:

Post a Comment

Comment from personal blog

Subscribe to: Post Comments (Atom)

My Blog List